GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease

February 6, 2013 7:21 AM EST
Get Alerts GSK Hot Sheet
Trade GSK Now!
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p, versus 31.2p reported last year. Revenue for the quarter came in at GBP6.8 billion, versus GBP6.98 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment